Maternal periconceptional illicit drug use and the risk of congenital malformations

Epidemiology

Volumn 20, Issue 1, 2009, Pages 60-66

  Van Gelder, Marleen M H J ^a,b   Reefhuis, Jennita ^a   Caton, Alissa R ^c   Werler, Martha M ^d   Druschel, Charlotte M ^c   Roeleveld, Nel ^b  

^a NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

^d BOSTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABIS; CENTRAL STIMULANT AGENT; COCAINE; ILLICIT DRUG; OPIATE; PSYCHEDELIC AGENT;

ANENCEPHALUS; ARTICLE; BIRTH DEFECT; CAUSAL ATTRIBUTION; CLEFT PALATE; CONGENITAL MALFORMATION; CONTROLLED STUDY; FIRST TRIMESTER PREGNANCY; GASTROSCHISIS; HUMAN; INFANT; MAJOR CLINICAL STUDY; PREGNANCY; PRIORITY JOURNAL; RISK FACTOR;

ABNORMALITIES, DRUG-INDUCED; ADULT; DATABASES AS TOPIC; FEMALE; HEALTH SURVEYS; HUMANS; INFANT, NEWBORN; INTERVIEWS AS TOPIC; MOTHERS; PREGNANCY; RISK ASSESSMENT; SUBSTANCE-RELATED DISORDERS; UNITED STATES; YOUNG ADULT;

EID: 67651100707     PISSN: 10443983     EISSN: None     Source Type: Journal    
DOI: 10.1097/EDE.0b013e31818e5930     Document Type: Article

References (35)

1. Substance Abuse and Mental Health Services Administration. Results from the 2004 National Survey on Drug Use and Health: National Findings. NSDUH Series H-28, SMA 05-4062. Rockville: Office of Applied Studies; 2005.
2. Bauer CR, Langer JC, Shankaran S, et al. Acute neonatal effects of cocaine exposure during pregnancy. Arch Pediatr Adolesc Med. 2005; 159:824-834.
3. Behnke M, Eyler FD, Garvan CW, et al. The search for congenital malformations in newborns with fetal cocaine exposure. Pediatrics. 2001;107:E74.
4. Arria AM, Derauf C, Lagasse LL, et al. Methamphetamine and other substance use during pregnancy: preliminary estimates from the Infant Development, Environment, and Lifestyle (IDEAL) study. Matern Child Health J. 2006;10:293-302.
5. El-Mohandes A, Herman AA, Nabil El-Khorazaty M, et al. Prenatal care reduces the impact of illicit drug use on perinatal outcomes. J Perinatol. 2003;23:354 -360.
6. Shaw GM, Velie EM, Morland KB. Parental recreational drug use and risk for neural tube defects. Am J Epidemiol. 1996;144:1155-1160.
7. Witter FR, Niebyl JR. Marijuana use in pregnancy and pregnancy outcome. Am J Perinatol. 1990;7:36 -38.
8. Lee MJ. Marihuana and tobacco use in pregnancy. Obstet Gynecol Clin North Am. 1998;25:65-83.
9. Williams LJ, Correa A, Rasmussen S. Maternal lifestyle factors and risk for ventricular septal defects. Birth Defects Res Part A Clin Mol Teratol. 2004;70:59-64.
10. Torfs CP, Velie EM, Oechsli FW, et al. A population-based study of gastroschisis: demographic, pregnancy, and lifestyle risk factors. Teratology. 1994;50:44 -53.
11. Lipshultz SE, Frassica JJ, Orav EJ. Cardiovascular abnormalities in infants prenatally exposed to cocaine. J Pediatr. 1991;118:44 -51.
12. Shaw GM, Malcoe LH, Lammer EJ, et al. Maternal use of cocaine during pregnancy and congenital cardiac anomalies (letter). J Pediatr. 1991;118:167-168.
13. Morrison JJ, Chitty LS, Peebles D, et al. Recreational drugs and fetal gastroschisis: maternal hair analysis in the peri-conceptional period and during pregnancy. BJOG. 2005;112:1022-1025.
14. Hoyme HE, Jones KL, Dixon SD, et al. Prenatal cocaine exposure and fetal vascular disruption. Pediatrics. 1990;85:743-747.
15. Chavez GF, Mulinare J, Cordero JF. Maternal cocaine use during early pregnancy as a risk factor for congenital urogenital anomalies. JAMA. 1989;262:795-798.
16. Battin M, Albersheim S, Newman D. Congenital genitourinary tract abnormalities following cocaine exposure in utero. Am J Perinatol. 1995;12:425-428.
17. Singh J. Gastroschisis is caused by the combination of carbon monoxide and protein-zinc deficiencies in mice. Birth Defects Res Part B Dev Reprod Toxicol. 2003;68:355-362.
18. Alexander PG, Tuan RS. Carbon monoxide-induced axial skeletal dysmorphogenesis in the chick embryo. Birth Defects Res Part A Clin Mol Teratol. 2003;67:219 -230.
19. Khare M, Taylor AH, Konje JC, et al. Delta9-tetrahydrocannabinol inhibits cytotrophoblast cell proliferation and modulates gene transcription. Mol Hum Reprod. 2006;12:321-333.
20. Webster WS, Brown-Woodman PD. Cocaine as a cause of congenital malformations of vascular origin: experimental evidence in the rat. Teratology. 1990;41:689-697.
21. Jones KL. Developmental pathogenesis of defects associated with prenatal cocaine exposure: fetal vascular disruption. Clin Perinatol. 1991; 18:139 -146.
22. Rasmussen SA, Olney RS, Holmes LB, et al. Guidelines for case classification for the National Birth Defects Prevention Study. Birth Defects Res Part A Clin Mol Teratol. 2003;67:193-201.
23. Yoon PW, Rasmussen SA, Lynberg MC, et al. The National Birth Defects Prevention Study. Public Health Rep. 2001;116(suppl 1):32-40.
24. National Institute on Drug Abuse. Commonly abused drugs-National Institute on Drug Abuse web site-. December 7, 2004. Available at: http://www.drugabuse.gov/DrugPages/DrugsofAbuse.html. Accessed July 11, 2006.
25. U.S. Census Bureau. Income 2001 -U.S. Census Bureau web site-. May 13, 2004. Available at: http://www.census.gov/hhes/income/income01/ statemhi.html. Accessed September 19, 2006.
26. Lester BM, ElSohly M, Wright LL, et al. The Maternal Lifestyle Study: drug use by meconium toxicology and maternal self-report. Pediatrics. 2001;107:309 -317.
27. Eyler FD, Behnke M, Wobie K, et al. Relative ability of biologic specimens and interviews to detect prenatal cocaine use. Neurotoxicol Teratol. 2005;27:677-687.
28. Finer LB, Henshaw SK. Disparities in rates of unintended pregnancy in the United States, 1994 and 2001. Perspect Sex Reprod Health. 2006; 38:90 -96.
29. Than LC, Honein MA, Watkins ML, et al. Intent to become pregnant as a predictor of exposures during pregnancy: is there a relation? J Reprod Med. 2005;50:389 -396.
30. Buckley NE, Hansson S, Harta G, et al. Expression of the CB1 and CB2 receptor messenger RNAs during embryonic development in the rat. Neuroscience. 1998;82:1131-1149.
31. Hatch EE, Bracken MB. Effect of marijuana use in pregnancy on fetal growth. Am J Epidemiol. 1986;124:986 -993.
32. Geber WF, Schramm LC. Effect of marihuana extract on fetal hamsters and rabbits. Toxicol Appl Pharmacol. 1969;14:276 -282.
33. Bingol N, Fuchs M, Diaz V, et al. Teratogenicity of cocaine in humans. J Pediatr. 1987;110:93-96.
34. van Rooij IA, Wegerif MJ, Roelofs HM, et al. Smoking, genetic polymorphisms in biotransformation enzymes, and nonsyndromic oral clefting: a gene-environment interaction. Epidemiology. 2001;12:502-507.
35. Kaneko S, Battino D, Andermann E, et al. Congenital malformations due to antiepileptic drugs. Epilepsy Res. 1999;33:145-158.